Snowden Capital Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Snowden Capital Advisors LLC

  • $3.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$28.0 - $40.56 $20,860 - $30,217
745 Added 7.78%
10,318 $418,000
Q3 2022

Nov 09, 2022
BUY
$29.63 - $48.31 $98,104 - $159,954
3,311 Added 52.87%
9,573 $316,000
Q2 2022

Aug 12, 2022
BUY
$27.79 - $50.61 $174,020 - $316,919
6,262 New
6,262 $220,000

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
91.1M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.96B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email